Abbott Laboratories (ABT) Short-Term Debt repayments (2017 - 2021)
Abbott Laboratories' (ABT) quarterly Short-Term Debt repayments came in at $195.0 million in Q4 2021, down 59.29% quarter-over-quarter from $479.0 million in Q1 2017.
Abbott Laboratories (ABT) Short-Term Debt repayments (2017 - 2021) Analysis & Trends
Abbott Laboratories has disclosed Short-Term Debt repayments across 2 years of filings, most recently posting $195.0 million for Q4 2021.
- Short-Term Debt repayments for Q4 2021 came in at $195.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $195.0 million (changed N/A YoY), and the FY2021 annual result was $195.0 million, changed N/A from the prior year.
- Short-Term Debt repayments came in at $195.0 million for Q4 2021 at Abbott Laboratories, down from $479.0 million in the prior quarter.
- In the past five years, Short-Term Debt repayments ranged from a high of $479.0 million in Q1 2017 to a low of $195.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 259.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 195.00 Mn |
| Dec 31, 2021 | 195.00 Mn |
| Mar 31, 2017 | 479.00 Mn |
| Mar 31, 2017 | 479.00 Mn |